ITEM VIEW

Comorbidity in generalized anxiety disorder: Impact and implications

dc.contributor.authorStein D.J.
dc.contributor.authorNutt
dc.contributor.authorBallenger
dc.contributor.authorDavidson
dc.contributor.authorWittchen
dc.contributor.authorLecrubier
dc.contributor.authorBorkovec
dc.date.accessioned2011-05-15T16:01:57Z
dc.date.available2011-05-15T16:01:57Z
dc.date.issued2001
dc.identifier.citationJournal of Clinical Psychiatry
dc.identifier.citation62
dc.identifier.citationSUPPL. 11
dc.identifier.issn1606689
dc.identifier.urihttp://hdl.handle.net/10019.1/12235
dc.description.abstractStudying comorbidity may be particularly useful in shedding light on the nature, course, and management of generalized anxiety disorder (GAD). This article reviews the common comorbidities in GAD, their impact on functioning and on medical utilization, and their implications for treatment. Comorbidity in this area is complex in that GAD may be primary (predating other illnesses) or secondary (following other conditions). Nevertheless, studies demonstrate the high prevalence of patients with a matrix of anxious-somatic-depressive symptoms and show that GAD comorbidity is associated with both increased disability and increased medical utilization. Clinical implications of this work include the need for rigorous assessment of anxiety, somatic, and depressive symptoms in patients who present with any one of these sets of complaints and the possibility that early treatment of GAD may be critical in preventing subsequent morbidity.
dc.subjectantidepressant agent
dc.subjectbenzodiazepine derivative
dc.subjectnortriptyline
dc.subjectanxiety neurosis
dc.subjectattention deficit disorder
dc.subjectcomorbidity
dc.subjectconference paper
dc.subjectdepression
dc.subjectdisability
dc.subjecthealth care cost
dc.subjecthealth care utilization
dc.subjecthuman
dc.subjectpanic
dc.subjectpersonality disorder
dc.subjectposttraumatic stress disorder
dc.subjectpriority journal
dc.subjectpsychotherapy
dc.subjectsomatization
dc.subjectstereotypy
dc.subjectsubstance abuse
dc.subjecttrichotillomania
dc.subjectAnxiety Disorders
dc.subjectComorbidity
dc.subjectDepressive Disorder
dc.subjectHealth Services
dc.subjectHumans
dc.subjectMental Health Services
dc.subjectPrevalence
dc.subjectSeverity of Illness Index
dc.subjectSomatoform Disorders
dc.subjectSubstance-Related Disorders
dc.titleComorbidity in generalized anxiety disorder: Impact and implications
dc.typeConference Paper
dc.description.versionConference Paper


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

ITEM VIEW